ARTICLE | Clinical News
Geodon ziprasidone regulatory update
February 2, 2015 8:00 AM UTC
Geodon is approved in the U.S. to treat schizophrenia, for acute treatment of bipolar manic or mixed episodes, for maintenance treatment of bipolar disorder and for acute agitation in schizophrenic pa...